Home » Newsletters » BioWorld Science

BioWorld Science

May 19, 2004

View Archived Issues

Efficacy of ezetimibe shown in hypercholesterolemic kidney transplant patients

Official webcasts from the American Urological Association's 99th Annual Meeting

Novel potent tryptase inhibitor described by BMS

Novel factor Xa inhibitor with potent anticoagulant and antithrombotic activity

Argenta Discovery seeks to out-license HDAC inhibitor project

Protein Design Labs discontinues development of daclizumab for ulcerative colitis

BMS, Gilead and Merck to develop fixed-dose combination of three anti-HIV drugs

BMS and Solvay to codevelop SLV-319

SkyePharma enters agreement for undisclosed cardiovascular pipeline product

Chiron Vaccines' powder injection vaccine technology development to continue under PowderMed

Benitec gains ddRNAi-based therapeutic for HCV through Avocel acquisition

NIH initiates 5-year study of severe, treatment-resistant systemic lupus

Phase IIa study of AD-237 in treatment of COPD shows positive results

Guilford expands international network for Gliadel Wafer through second agreement

Lasofoxifene counters bone loss in postmenopausal women

Strontium ranelate reduces hip fracture risk in older postmenopausal women

Intravenous ferumoxytol effective in anemic patients on hemodialysis

Lanthanum carbonate findings reported at NKF meeting

In vitro and clinical data on dalbavancin reported at ECCMID

Bay-73-7388 demonstrates efficacy in vitro and in vivo

Talnetant stimulates peristalsis without affecting normal intestinal motility

Benefits of the antioxidant tetrathiomolybdate in experimental colitis

TC-240312 reported to inhibit the production of IL-8 in the intestinal mucosa

Merck claims radiolabeled NK1 antagonists and their use as diagnostic agents

Portela describes peripherally acting dopamine beta-hydroxylase inhibitors

Janssen presents p38/TNF-alpha inhibitors and their use in inflammatory disorders

Two series of HIV RT inhibitors in early development at Pfizer

Novel Abl kinase inhibitors identified by Novartis researchers

Novel 11a-azaerythromycin analogues and their use reported by Pliva

New 5-HT6 antagonists prepared and tested by Roche team

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...